Yüceer, R.O.; Aydın, S.; Gelir, I.; Koc, T.; Tuncer, E.; Ucar, M.
Exploring the Prognostic Role of Trop-2, CD47, and CD163 Expression Levels on Survival Outcomes in Patients with Triple-Negative Breast Cancer. Diagnostics 2025, 15, 232.
https://doi.org/10.3390/diagnostics15020232
AMA Style
Yüceer RO, Aydın S, Gelir I, Koc T, Tuncer E, Ucar M.
Exploring the Prognostic Role of Trop-2, CD47, and CD163 Expression Levels on Survival Outcomes in Patients with Triple-Negative Breast Cancer. Diagnostics. 2025; 15(2):232.
https://doi.org/10.3390/diagnostics15020232
Chicago/Turabian Style
Yüceer, Ramazan Oguz, Sedanur Aydın, Iclal Gelir, Tulay Koc, Ersin Tuncer, and Mahmut Ucar.
2025. "Exploring the Prognostic Role of Trop-2, CD47, and CD163 Expression Levels on Survival Outcomes in Patients with Triple-Negative Breast Cancer" Diagnostics 15, no. 2: 232.
https://doi.org/10.3390/diagnostics15020232
APA Style
Yüceer, R. O., Aydın, S., Gelir, I., Koc, T., Tuncer, E., & Ucar, M.
(2025). Exploring the Prognostic Role of Trop-2, CD47, and CD163 Expression Levels on Survival Outcomes in Patients with Triple-Negative Breast Cancer. Diagnostics, 15(2), 232.
https://doi.org/10.3390/diagnostics15020232
